COVID-19 outbreak among French firefighters, Marseille, France, 2020.
COVID-19
SARS-CoV-2
asymptomatic
neutralisation assay
presymptomatic
serology
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
entrez:
15
10
2021
pubmed:
16
10
2021
medline:
21
10
2021
Statut:
ppublish
Résumé
We investigated a COVID-19 outbreak at a fire station in Marseille, France. Confirmed cases were defined as individuals with positive SARS-CoV-2 reverse transcription (RT)-PCR and/or neutralising antibodies. All 85 firefighters at work during the outbreak period were included after questioning and sampled for RT-PCR and viral neutralisation assay. Twenty-three firefighters were confirmed positive, 19 of them were symptomatic, and four asymptomatic cases were confirmed by virus neutralisation. A total of 22 firefighters had specific neutralising antibodies against SARS-CoV-2. Neutralising antibodies were found in four asymptomatic and 18 symptomatic cases. Eleven symptomatic cases had high titres (≥ 1:80). The earliest detection of neutralising antibodies was 7 days after symptom onset, and 80% had neutralising antibodies 15 days after onset. One viral culture was positive 13 days after onset. The attack rate was 27%. We identified two introductions of the virus in this outbreak, through a presymptomatic and a paucisymptomatic case. Asymptomatic cases were not the source of a third generation of cases, although they worked without wearing a mask, indicating that asymptomatic cases did not play a significant role in this outbreak. Management and strategy based on early research of clinical signs associated with self-quarantine was effective.
Identifiants
pubmed: 34651571
doi: 10.2807/1560-7917.ES.2021.26.41.2001676
pmc: PMC8518307
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Med Virol. 2020 Jun;92(6):568-576
pubmed: 32134116
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Emerg Infect Dis. 2020 Jul;26(7):
pubmed: 32364890
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Int J Biol Sci. 2020 Mar 15;16(10):1718-1723
pubmed: 32226289
Ann Intern Med. 2020 May 5;172(9):577-582
pubmed: 32150748
J Infect. 2020 Jun;80(6):e1-e13
pubmed: 32283156
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Emerg Infect Dis. 2020 Oct;26(10):2484-2487
pubmed: 32579877
Wellcome Open Res. 2020 Apr 1;5:58
pubmed: 32685697
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
PLoS Med. 2020 Sep 22;17(9):e1003346
pubmed: 32960881
J Infect Dis. 2006 Mar 15;193(6):792-5
pubmed: 16479513
J Med Virol. 2021 Mar;93(3):1414-1420
pubmed: 32767703
Nat Med. 2020 Jun;26(6):845-848
pubmed: 32350462
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Science. 2020 Aug 14;369(6505):812-817
pubmed: 32434946
Emerg Infect Dis. 2020 Aug;26(8):1915-1917
pubmed: 32320641